Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Lymphoblastic Leukemia
New acute lymphoblastic leukemia in children research from University of Berlin, Department of Pediatric Oncology discussed
April 13th, 2008
Fresh data on acute lymphoblastic leukemia are presented in the report 'High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia.' According to a study from Berlin, Germany, "High-dose methotrexate (MTX) has been extensively used for treatment of acute lymphoblastic leukemia (ALL). To determine the optimal dose of MTX in childhood relapsed ALL, the ALL Relapse Berlin-Frankfurt-Münster (ALL-REZ BFM) Study Group performed this prospective randomized study." "A total of 269 children with a first early/late isolated (n=156) or combined (n=68) bone marrow or any isolated extramedullary relapse (n=45) of precursor...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-13)
|
